Literature DB >> 6234330

Observations on drug-induced toxic epidermal necrolysis in Singapore.

H L Chan.   

Abstract

Fifteen patients with toxic epidermal necrolysis (TEN) were studied. In all of them the TEN was related to drug ingestion and believed to be drug-induced. The drugs implicated include pyrazolone derivatives, allopurinol, barbiturates, tetracycline, phenytoin, and penicillamine. Possible etiologic co-factors are infections, cancer, and the systemic lupus erythematosus diathesis. The extent of skin loss varied from 25% to almost 100% involvement of the total body surface. Seven of the fifteen patients had more than 75% epidermal loss. Three deaths were recorded (20%). From observations on these fifteen patients it was found that a single drug can cause two "reaction" patterns, namely, Stevens-Johnson syndrome (or erythema multiforme) and TEN, at the same time or at different times in one and the same patient. It is stressed that from the prognostic and therapeutic viewpoints patients with TEN may be equated to patients with extensive partial-thickness burns and should be treated in a burn unit.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234330     DOI: 10.1016/s0190-9622(84)80317-5

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

1.  Outbreak of Stevens-Johnson syndrome/toxic epidermal necrolysis associated with mebendazole and metronidazole use among Filipino laborers in Taiwan.

Authors:  Kow-Tong Chen; Shiing-Jer Twu; Hong-Jen Chang; Ruey-Shiung Lin
Journal:  Am J Public Health       Date:  2003-03       Impact factor: 9.308

Review 2.  Severe cutaneous adverse drug reactions.

Authors:  Rajesh Verma; Biju Vasudevan; Vijendran Pragasam
Journal:  Med J Armed Forces India       Date:  2013-03-17

Review 3.  Clinical features and management of severe dermatological reactions to drugs.

Authors:  M C Raviglione; A Pablos-Mendez; R Battan
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

Review 4.  Drug-induced severe skin reactions. Incidence, management and prevention.

Authors:  P Wolkenstein; J Revuz
Journal:  Drug Saf       Date:  1995-07       Impact factor: 5.606

5.  How frequent are notified severe cutaneous adverse reactions to Fansidar?

Authors:  D Stürchler; M L Mittelholzer; L Kerr
Journal:  Drug Saf       Date:  1993-02       Impact factor: 5.606

Review 6.  Allergic emergencies encountered by the dermatologist. Severe cutaneous adverse drug reactions.

Authors:  P Wolkenstein; J Revuz
Journal:  Clin Rev Allergy Immunol       Date:  1999       Impact factor: 10.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.